Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01630200 · COMPLETED
Trial details
- NCT number
- NCT01630200
- Sponsor
- LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-01-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.